No Picture
Trading Ideas

Goldman Sachs Predicts Over 40% Rally for These 3 Stocks

A new wave of optimism is splashing onto the Street. Investment firm Goldman Sachs just gave its three-month stock forecast a boost, lifting it from Neutral to Overweight, with it also projecting “high single-digital returns” for global stocks over the next year.What’s behind this updated approach? Goldman Sachs strategist Christian Mueller-Glissmann cites the impressive rebound in global earnings growth and reduced equity costs as the drivers of the estimate revision. On top of this, a “broader procyclical shift” in stocks and other assets could take place during the remainder of this year.“We have shifted more cyclical on sectors and themes …read more […]

Newsmakers

NexTech (OTC: NEXCF) Launching New AR for eCommerce Hologram Marketing Platform and New Human Supplement Product Line ‘TruLyfe’

VANCOUVER, British Columbia, Sept. 30, 2020  — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging leader in augmented reality for eCommerce, AR learning applications, and AR-enhanced video conferencing and virtual events is pleased […]

Newsmakers

ImagineAR (OTC: IPNFF) Signs Two-Year Agreement with Valencia C.F. Of LaLiga To Provide Interactive Augmented Reality Experiences for Almost 7 Million Fans Around The World

Valencia C.F. Become First LaLiga Team to Leverage Augmented Reality for Fan Activation & Engagement VANCOUVER, BC and ERIE, Pa., Sept. 30, 2020  – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that […]

No Picture
Trading Ideas

U.S. court voids $448 million award against AbbVie, AndroGel partner

Ruling in a case brought by the Federal Trade Commission, the 3rd U.S. Circuit Court of Appeals in Philadelphia said the lower court judge who ordered the disgorgement by AbbVie and Besins Healthcare Inc lacked authority under applicable federal law. The appeals court also upheld an order finding AbbVie and Besins liable for monopolization, based upon its holding that they had filed a sham patent infringement lawsuit against Perrigo Co to delay the launch of generic AndroGel. …read more […]